InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,476.88
(
0.07%
)
US TECH 100
19,262.80
(
0.02%
)
Dow Jones
39,116.76
(
-0.05%
)
Brent Oil
84.79
(
-0.26%
)
Bitcoin
63,625.15
(
-1.84%
)
Post# of 647817
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Covid19freak

Send PM Follow Ignore
Followers 10
Posts 1251
Boards Moderated 0
Alias Born 07/20/2020

Covid19freak

Re: None

Friday, 08/05/2022 11:09:02 AM

Friday, August 05, 2022 11:09:02 AM

Post# of 647817
(APTX) $0.53..Cash $1.40 per shr --Data readout IMMINENT

Company expects to report results from Phase 2b study of NYX-2925 in fibromyalgia in August

Data from Phase 2 study of NYX-458 in cognitive impairment expected in 1Q 2023

IND cleared for NIH grant-funded evaluation of NYX-783 in opioid use disorder

$85 million cash balance provides operational runway into 2024 and enables readouts from multiple Phase 2 studies
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up